We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

(Video) GlaxoSmithKline plc’s Bribery Allegations

GlaxoSmithKline plc (LON:GSK) faces fresh allegations of bribery abroad.

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

With GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) facing fresh allegations of bribery, this time in Poland, Owain Bennallack focuses on those made in relation to Iraq and asks whether this newsflow ought to diminish the appeal of the company as a share…

https://youtu.be/8ZD3FVwHCwE

Should you buy Rolls Royce shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Owain owns shares in GlaxoSmithKline. The Motley Fool has recommended shares in GlaxoSmithKline.

More on Investing Videos

Aston Martin DBX - rear pic of trunk
Investing Videos

“£10k invested in Aston Martin shares a year ago is now worth…” [VIDEO]

VIDEO: shares in Aston Martin have remained stuck in reverse over the last year. Should investors should consider buying the…

Read more »

Tesco employee helping female customer
Investing Videos

“£10k invested in Tesco shares one week ago is now worth” [VIDEO]

VIDEO: shares in Tesco have seen more volatility than usual. Two Fools dive into what's behind the recent price movement.

Read more »

Tesla car at super charger station
Investing Videos

“£10,000 invested in Tesla stock a fortnight ago is now worth…” [VIDEO]

VIDEO: some retail investors have been trying to catch the proverbial ‘falling knife’ with Tesla's stock.

Read more »

Worker on sofa and team on laptop screen talking and discussion in video conference and dog interruption.
Investing Videos

What’s behind Rolls-Royce shares’ recent move higher? [VIDEO]

VIDEO: A pair of Fools (upper case F!) take a look at two reasons behind the 25% gain that Rolls-Royce…

Read more »

Investing Videos

Is the FTSE 100 overvalued?

VIDEO: One Fool scrutinises the FTSE 100 (INDEXFTSE: UKX).

Read more »

Investing Videos

Can the price of Rio Tinto plc & BHP Billiton plc double again?

VIDEO: One Fool ponders the near-term future of Rio Tinto plc (LON:RIO) and BHP Billion plc (LON:BLT)

Read more »

Investing Videos

Why these expensive shares could keep falling in 2017

VIDEO: One Fool doesn't like the near-term forecast for consumer staples giants...

Read more »

Oil rig
Investing Videos

BP & Shell should be big winners from the big OPEC deal

VIDEO: One Fool looks at the beneficiaries from OPEC's decision to cut oil production.

Read more »